drugset / Trial / NCT02160678
Generic Tazarotene Cream, 0.1% in the Treatment of Acne Vulgaris
RandomizedParallel-groupTriple-blindTreatment
Summary
To compare the safety and efficacy profiles of Tazarotene Cream, 0.1 % to the reference listed drug Tazorac® (tazarotene) Cream, 0.1 % in order to demonstrate bioequivalence, and to demonstrate superiority of the 2 active creams over that of the cream vehicle (placebo) in the treatment of acne vulgaris.
Timeline
- Start
- 2014-05
- Primary completion
- 2015-07
- Completion
- 2015-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tazarotene | Small molecule | 0.1 % | Topical |